HCA Healthcare Inc. (HCA)
Health Care2 articles
Price chart
HCA Healthcare Inc. (HCA) overview
HCA Healthcare is one of the largest U.S. hospital operators. It is a member of the S&P 500 and is classified in the Health Care sector — pharmaceutical, biotech, device and managed-care companies.
HCA Healthcare Inc. trades on the NYSE under the ticker symbol HCA. As of the most recent market data, the stock was priced around $371.18, down 3.77% on the session, giving HCA Healthcare Inc. a market capitalization of roughly $82.34B.
Over the past 52 weeks, HCA has traded between $330.00 and $556.52. Shares are valued at a trailing price-to-earnings (P/E) ratio of about 13.3, a common gauge of how richly the market prices the company's earnings. HCA Healthcare Inc. also pays a dividend, currently yielding around 84.00%.
Key statistics
Informational only, not financial advice. Content is AI-generated and may contain errors. How this works.
Why investors watch HCA
As one of the larger companies in the Health Care sector, HCA Healthcare Inc. is closely followed by investors and often moves with broader trends across pharmaceutical, biotech, device and managed-care companies. Traders watch HCA for earnings reports, analyst rating changes, and headlines that can shift sentiment — each of which is summarized on this page as it breaks.
Market Mood
Latest HCA news
HCA (HCA) Stock Gains Momentum on Guidance Report
HCA Healthcare (HCA) has seen positive stock performance following updated guidance. The company projected earnings per share of $3.30-$3.50 for the upcoming quarter, indicating a potential 10% increase compared to previous estimates. This upward revision is significant amidst a competitive healthcare market. HCA's stock is poised to benefit from the anticipated growth, which could attract more investors given current trading volumes.
Read More: HCA (HCA) Stock Gains Momentum on Guidance Report
HCA (HCA) Q1 2026 Earnings Call Highlights Key Financials
During the Q1 2026 earnings call, HCA (HCA) reported revenue growth of 5% year-over-year, reaching $14.2 billion. The company also shared an adjusted EPS of $3.45, reflecting strong performance compared to analyst expectations. Additionally, operating income rose to $2.1 billion, compared to $2.0 billion in the same quarter last year. This positive financial performance may indicate robust demand for healthcare services and could positively influence HCA's stock price in the upcoming months.
Read More: HCA (HCA) Q1 2026 Earnings Call Highlights Key FinancialsMore Health Care stocks
Frequently asked questions
Is HCA Healthcare Inc. in the S&P 500?
Yes. HCA Healthcare Inc. (HCA) is a member of the S&P 500 index, classified in the Health Care sector.
What sector is HCA in?
HCA Healthcare Inc. is classified in the Health Care sector of the S&P 500 — pharmaceutical, biotech, device and managed-care companies.
Where can I find the latest HCA news?
This page collects recent HCA Healthcare Inc. (HCA) news and market analysis, each article summarized by AI and tagged with bullish, bearish, or neutral sentiment.
What is HCA Healthcare Inc.'s stock price?
As of the most recent market data, HCA Healthcare Inc. (HCA) traded at approximately $371.18. Prices move throughout the trading day, so this reflects the latest available quote rather than a live price.
What is HCA Healthcare Inc.'s market cap?
HCA Healthcare Inc. has a market capitalization of roughly $82.34B, based on its most recent share price and shares outstanding.
What is HCA's P/E ratio?
HCA trades at a trailing price-to-earnings ratio of about 13.3. The P/E ratio compares a company's share price to its earnings per share.